Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.420
+0.010 (0.23%)
At close: Dec 5, 2025, 4:00 PM EST
4.450
+0.029 (0.67%)
After-hours: Dec 5, 2025, 5:26 PM EST
Arbutus Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 850 | 620 | 419 | 365 | 526 | 301 | |
| Market Cap Growth | 27.45% | 47.80% | 15.00% | -30.72% | 74.57% | 74.57% | |
| Enterprise Value | 761 | 496 | 285 | 189 | 556 | 353 | |
| Last Close Price | 4.42 | 3.27 | 2.50 | 2.33 | 3.89 | 3.55 | |
| PS Ratio | 57.78 | 100.41 | 23.11 | 9.34 | 47.89 | 43.60 | |
| PB Ratio | 10.96 | 6.36 | 3.95 | 2.66 | 3.11 | 2.96 | |
| P/TBV Ratio | 10.98 | 6.36 | 3.95 | 2.66 | 3.11 | - | |
| EV/Sales Ratio | 52.10 | 80.32 | 15.69 | 4.85 | 50.59 | 51.00 | |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.08 | 0.09 | 0.11 | 0.22 | |
| Asset Turnover | 0.12 | 0.05 | 0.11 | 0.20 | 0.06 | 0.06 | |
| Quick Ratio | 18.31 | 8.03 | 5.71 | 4.51 | 13.92 | 13.06 | |
| Current Ratio | 18.80 | 8.15 | 5.87 | 4.60 | 14.32 | 13.39 | |
| Return on Equity (ROE) | -45.88% | -68.76% | -59.99% | -45.35% | -56.19% | -72.97% | |
| Return on Assets (ROA) | -16.46% | -31.68% | -28.70% | -19.76% | -26.22% | -29.51% | |
| Return on Capital (ROIC) | -20.03% | -40.08% | -36.93% | -23.40% | -28.63% | -32.60% | |
| Return on Capital Employed (ROCE) | -33.90% | -60.30% | -64.00% | -38.90% | -37.10% | -44.90% | |
| Earnings Yield | -4.97% | -11.28% | -17.38% | -19.05% | -14.49% | -21.15% | |
| FCF Yield | -5.34% | -10.50% | -20.74% | -9.84% | -12.99% | -17.14% | |
| Buyback Yield / Dilution | -5.88% | -11.84% | -9.95% | -42.07% | -40.10% | -32.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.